Business
Novavax chief ‘not able to predict’ Australian approval date for vaccine – Sydney Morning Herald
The company behind the third major COVID vaccine that Australia has ordered has been delayed in filing for global approvals.
The chief executive of coronavirus vaccine maker Novavax has admitted the company will have to delay filing for approvals of the product until July and will not put a date on when the vaccine is likely to receive the green light in Australia.
The Australian government has ordered 51 million doses of the Novavax vaccine, which had been expected to start being delivered as early as September this year.
Novavax said the trial, which enrolled 15,000 people aged 18 to 84, was expected to be used to apply…
-
Noosa News22 hours agoLaidley e-scooter death: Tragic new details after Summah Richards killed in freak accident
-
General23 hours agoMinjee Lee rallies after third-round meltdown to share fifth place at LA Championship
-
General16 hours agoUkraine says Russia has ramped up attacks despite ‘Easter truce’
-
General21 hours agoEaster drowning toll in NSW rises after fisherman swept off rocks in Sydney’s south